Clinical Trials
5 trialsNCT03520660 2026-05-22
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT01082419 2026-05-14
NARFI
University Hospital, Bordeaux
Phase NA Completed
NCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT02968810 2026-05-04
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06096779 2026-05-04
Kirros
Genentech, Inc.
Phase 2 Recruiting